The program is geared toward young scientists who aim to pursue integrated; translational research focused on advancing promising new nanotechnology-based diagnostics and therapeutics to improve cancer care. The fellows will commit most of their time to research and technical training, with the course participation accounting for no more than 10% of their effort. The research projects will be clinically and biologically relevant to cancer and will examine nanoscience and nanotechnology as a potential solution. A detailed mentoring plan will also be developed for each fellow, including the project's aims and multidisciplinary coursework and seminar experiences.
The main goal of this training program is to educate future leaders in the broad field of nanotechnology with specific interests in cancer-related applications that are keenly aware of the needs and demands of the clinical environment and the major challenges of translational research. After completing this program, the trainees will be able to demonstrate the ability to carry out independent translational research in cancer nanotechnology. Didactic coursework will prepare them to contribute to research projects that directly address barriers to the translation of nanotechnology-based approaches and develop the skills needed to define and lead such projects. Trainees will develop a foundational background in the field by taking at least four didactical courses related to translational cancer or nanotechnology topics. Trainees will gain essential writing skills through scientific writing seminars and by writing an NIH grant proposal. Finally, trainees will gain important lab management skills by participating in a short hands-on course introducing laboratory and project management.
An individual holding a recent (within three years) Ph.D. with training in physical science, chemistry, or bioengineering with a demonstrated background and interest in nanotechnology. Holders of an M.D. degree will be eligible for the program if they show a strong interest in translational cancer nanotechnology research.
This appointment is not part of a clinical training program; individuals holding an M.D. degree or equivalent are not permitted to engage in patient care activity.